Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 3, 2009, Pages 381-386

  Zhou, Wen Bin ^a   Bai, M ^b   Jin, Y ^b  

^a Hubei Provincial Corps Hospital   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Endostatin; Lung cancer; Pleural effusion; Tuberculosis; Vascular endothelial growth factor

Indexed keywords

ENDOSTATIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CALCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; TUBERCULOUS PLEURISY;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SMALL CELL; DIAGNOSIS, DIFFERENTIAL; ENDOSTATINS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62349103659     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 2006; 54: 1-9.
2. Bartter T, Santarelli R, Akers S M, et al. The evaluation of pleural effusion. Chest 1994; 106: 1209-1214.
3. Light R W. Malignant pleural effusions. In: Light R W, ed. Pleural diseases. 3rd ed. Baltimore, MD, USA: Williams and Wilkins, 1995: pp 94-116.
4. Dariusz Z, Ewa S, Szymon D, et al. VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis. Pneumonol Alergol Pol 2002; 70: 458-467.
5. Okamoto M, Kawabe T, Iwasaki Y, et al. Evaluation of interferon-γ, interferon-γ-inducing cytokines, and interferon-γ/-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med 2005; 145: 88-93.
6. Light R W. Physiology of the pleural space. In: Light R W, ed. Pleural diseases. 3rd ed. Baltimore, MD, USA: Williams and Wilkins, 1995: p 7.
7. Yanagawa H, Takeuchi E, Suzuki Y, et al. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer. Cancer Immunol Immunother 1999; 48: 396-400.
8. Hamed E A, Noweihi A M, Mohamed A Z, et al. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions. Respirology 2004; 9: 81-86.
9. Zebrowski B K, Yano S, Liu W, et al. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 1999; 5: 3364-3368.
10. Momi H, Matsuyama W, Inoue K, et al. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir Med 2002; 96: 817-822.
11. Sumi M, Kagohashi K, Satoh H, et al. Endostatin levels in exudative pleural effusions. Lung 2003; 181: 329-334.
12. Ruiz E, Aleman C, Alegre J, et al. Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions. Lung 2005; 183: 185-195.
13. Light R W. Diagnostic approach in a patient with pleural effusions. Eur Respir Monogr 2002; 22: 131-145.
14. Valdes L, Alvarez D, San Jose E, et al. Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in a region of high prevalence of tuberculosis. Thorax 1995; 50: 600-603.
15. Garcia-Pachon E, Padilla-Navas I, Dosda D, et al. Elevated level of CEA in nonmalignant pleural effusions. Chest 1997; 111: 643-647.
16. Romero S, Fernandez C, Arriero J M, et al. CEA, CA 15.3 and CYPRA 21-1 in serum and pleural fluid of patients with pleural effusions. Eur Respir J 1996; 9: 17-23.
17. Kandylis K, Vassilomanolakis M, Baziotis N. Diagnostic significance of the tumour markers CEA, CA 15-3 and CA-125 in malignant effusions in breast cancer. Ann Oncol 1990; 1: 435-438.
18. Canbakan S O, Atikcan S, Capan N, et al. Value of CEA, CA 19-9 and ADA in distinguishing of pleural effusions. Res Dis 1992; 3: 133-144.
19. Light R W. Tuberculous pleural effusions. In: Light R W, ed. Pleural diseases. 3rd ed. Baltimore, MD, USA: Williams and Wilkins, 1995: pp 154-166.
20. Garcia-Pachon E, Soler M J, Padilla-Navas I, et al. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis. Respiration 2005; 72: 486-489.
21. Valdes L, San Jose E, Alvarez D, et al. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Resp J 1996; 9: 747-751.
22. Andreasyan N A, Hairapetian H L, Sargisova Y G, et al. Activity of adenosine deaminase and its isoforms in pleural fluid in tuberculous pleuritis. Med Sci Monit 2002; 8: 708-712.
23. Burgess L J, Reuter H, Taljaard J J, et al. Role of biochemical tests in the diagnosis of large pericardial effusions. Chest 2002; 121: 495-499.
24. Ribera E, Martinez-Vazquez J M, Ocana I, et al. Interferon gama y adenosina desaminasa en las pleuritis. Med Clin (Barc) 1990; 94: 364-367. [Spanish]
25. Valdes L, San Jose E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase lysozyme and interferon gamma. Chest 1993; 103: 458-465.
26. Villegas M V, Labrada L A, Saravia N G. Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-γ in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest 2000; 118: 1355-1364.
27. Hiraki A, Aoe K, Eda R, et al. Comparison of six biological markers for the diagnosis of tuberculous pleuritis. Chest 2004; 125: 987-989.
28. Ena J, Valls V, Perez de Oteyza C, et al. Utilidad y limitaciones de la adenosina desaminasa en el diagnostico de la pleuresia tuberculosa. Estudio metaanalitico. Med Clin (Bare) 1990; 95: 333-335. [Spanish]
29. Querol J M, Barbe F, Manresa F, et al. Low value of adenosine deaminase in tuberculous pleural effusions. Eur Respir J 1990; 3: 586-587.
30. Sack U, Hoffmann M, Zhao X J, et al. Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 2005; 25: 600-604.
31. Cheng D, Rodríguez R M, Perkett E A, et al. Vascular endothelial growth factor in pleural fluid. Chest 1999; 116: 760-765.
32. Lim S C, Jung S I, Kim Y C, et al. Vascular endothelial growth factor in malignant and tuberculous pleural effusions. J Korean Med Sci 2000; 15: 279-283.
33. Grove C S, Lee Y C. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 2002; 8: 294-301.